Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Assets (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Return on Assets for 15 consecutive years, with 0.22% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets rose 13.0% year-over-year to 0.22%, compared with a TTM value of 0.22% through Sep 2025, up 13.0%, and an annual FY2024 reading of 0.3%, down 12.0% over the prior year.
  • Return on Assets was 0.22% for Q3 2025 at China Pharma Holdings, up from 0.26% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.15% in Q1 2021 and bottomed at 0.34% in Q3 2024.
  • Average Return on Assets over 5 years is 0.22%, with a median of 0.2% recorded in 2023.
  • The sharpest move saw Return on Assets surged 79bps in 2021, then fell -14bps in 2024.
  • Year by year, Return on Assets stood at 0.17% in 2021, then tumbled by -40bps to 0.23% in 2022, then increased by 17bps to 0.19% in 2023, then crashed by -73bps to 0.33% in 2024, then surged by 35bps to 0.22% in 2025.
  • Business Quant data shows Return on Assets for CPHI at 0.22% in Q3 2025, 0.26% in Q2 2025, and 0.31% in Q1 2025.